108 results
6-K
FENC
Fennec Pharmaceuticals Inc
19 Sep 06
Current report (foreign)
12:00am
very pleased to have the opportunity to be a part of this innovative cancer company, particularly as it advances its products through some key stages … innovative treatments that address important unmet medical needs in cancer. We currently have multiple products in the clinical stage of development, including
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
13 Jan 09
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
a leader in developing innovative treatments that address important unmet medical needs in cancer. For more information, please visit our website
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
2 Nov 10
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
, November, 1, 2010 /CNW/ - Adherex Technologies Inc. (TSX:AHX, Pink Sheets: ADHXF), a biopharmaceutical company dedicated to providing innovative
6-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
22 Jan 07
Adherex Announces Equity Offering Up to US$25 Million
12:00am
to be a leader in developing innovative treatments that address important unmet medical needs in cancer. We currently have multiple products in the clinical
6-K
FENC
Fennec Pharmaceuticals Inc
20 Jan 05
Current report (foreign)
12:00am
and development of novel cancer therapeutics. We aim to be a leader in developing innovative treatments that address important unmet medical needs
8-K
EX-99.1
nmgej6oa42h8v
28 Mar 07
Adherex Reports 2006 Fiscal Results
12:00am
6-K
EX-99.2
bi3ym
9 May 06
Adherex Announces US$6.5 Million Private Placement
12:00am
6-K
EX-99.2
x21ru0ywa bd0o91
31 Mar 06
Current report (foreign)
12:00am
8-K
EX-99.1
sg61qcq90
13 May 08
Adherex Reports First Quarter 2008 Financial Results
12:00am
8-K
EX-99.1
6red53a1gzuhfeq6fg
11 Dec 08
Adherex Receives AMEX Delisting Notice
12:00am
8-K
EX-99.1
l7hluml za21h7m
19 May 08
Adherex Announces Agreement for STS Phase Iii Data
12:00am
6-K
orybo
6 Dec 04
Current report (foreign)
12:00am
8-K
EX-99.1
iis3ixmhntfskh k6706
22 Feb 07
Adherex Completes US$25 Million Public Financing
12:00am
6-K
EX-99.1
e6b4j7
19 Jan 07
Adherex Buys Out Eniluracil Development Options from Glaxosmithkline
12:00am
6-K
EX-99.1
5vs3 knfc
15 Feb 07
Adherex Announces Filing of Final Prospectus
12:00am
8-K
EX-99.1
srktntspn 9nl8t1i
8 Nov 07
Adherex Reports Third Quarter 2007 Financial Results
12:00am
6-K
EX-99.1
0wimpwh6
11 May 05
Adherex Reports First Quarter 2005 Financial Results
12:00am
6-K
EX-99.1
hgsvody
16 May 06
Adherex Reports First Quarter 2006 Financial Results
12:00am
6-K
EX-99.1
cybbgf7i17ebo
12 Aug 05
Adherex Reports Second Quarter 2005 Financial Results
12:00am
6-K
EX-99.1
i520wbgb u0yw4w02
21 Mar 05
Current report (foreign)
12:00am